BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 9185494)

  • 1. Rhesus haemolytic disease of the newborn, complicating a quadruplet pregnancy.
    Elasoud K; McClure G; Halliday HL; Dornan JC
    Ulster Med J; 1997 May; 66(1):62-4. PubMed ID: 9185494
    [No Abstract]   [Full Text] [Related]  

  • 2. Preventing RhD haemolytic disease of the newborn. Services should be centralised for pregnancies affected by RhD haemolytic disease.
    Craig JS; McClure BG; Tubman TR
    BMJ; 1998 May; 316(7144):1611. PubMed ID: 9616034
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative analysis of the effects to date of the prevention of Rh incompatibility].
    Jedwabny A; Suchocki S; Bobrowska G
    Acta Haematol Pol; 1988; 19(1-2):56-8. PubMed ID: 2853507
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevention of hemolytic disease of the fetus and the newborn: it is necessary to act].
    Mannessier L; Alie-Daram S; Roubinet F; Valat AS; Depoortère MH; Fournié A; Puech F
    J Gynecol Obstet Biol Reprod (Paris); 2000 Sep; 29(5):441-4. PubMed ID: 11011272
    [No Abstract]   [Full Text] [Related]  

  • 5. Preventing rhesus D haemolytic disease of the newborn by giving anti-D immunoglobulin: are the guidelines being adequately followed?
    Harding K
    Br J Obstet Gynaecol; 1997 Jul; 104(7):869-70. PubMed ID: 9236664
    [No Abstract]   [Full Text] [Related]  

  • 6. Early plasmapheresis followed by high-dose γ-globulin treatment saved a severely Rho-incompatible pregnancy.
    Isojima S; Hisano M; Suzuki T; Sago H; Murashima A; Yamaguchi K
    J Clin Apher; 2011; 26(4):216-8. PubMed ID: 21506141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Infection risk factors in newborn infants with fetal erythroblastosis].
    Maszkiewicz W; Ornat K; Laskowska B; Irzyńska D; Manerowska D
    Acta Haematol Pol; 1988; 19(3-4):230-8. PubMed ID: 3150899
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prevention of neonatal alloimmune thrombocytopenia fetal maternal rhesus].
    Poissonnier MH
    J Gynecol Obstet Biol Reprod (Paris); 2007 Sep; 36 Suppl 1():S12-5. PubMed ID: 18228707
    [No Abstract]   [Full Text] [Related]  

  • 9. RhD hemolytic disease of the newborn.
    Bowman JM
    N Engl J Med; 1998 Dec; 339(24):1775-7. PubMed ID: 9845715
    [No Abstract]   [Full Text] [Related]  

  • 10. Preventing RhD haemolytic disease of the newborn.
    van Dijk B
    BMJ; 1997 Dec; 315(7121):1480-1. PubMed ID: 9420481
    [No Abstract]   [Full Text] [Related]  

  • 11. [Rhesus conflict during pregnancy].
    Sergienko NS
    Feldsher Akush; 1988 Mar; 53(3):28-32. PubMed ID: 3132402
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effectiveness of the treatment of severe cases of fetal erythroblastosis by intrauterine blood transfusion].
    Lukaszewicz E; Korzycki J; Debski R; Ciastoń W; Falecka K; Latoszewska W; Marianowski L
    Acta Haematol Pol; 1988; 19(3-4):212-6. PubMed ID: 3150897
    [No Abstract]   [Full Text] [Related]  

  • 13. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
    Kumpel BM
    Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
    [No Abstract]   [Full Text] [Related]  

  • 14. The economics of routine antenatal anti-D prophylaxis for pregnant women who are rhesus negative.
    Chilcott J; Tappenden P; Lloyd Jones M; Wight J; Forman K; Wray J; Beverley C
    BJOG; 2004 Sep; 111(9):903-7. PubMed ID: 15327602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rescue in inner space: management of Rh hemolytic disease.
    Liley HG
    J Pediatr; 1997 Sep; 131(3):340-2. PubMed ID: 9329405
    [No Abstract]   [Full Text] [Related]  

  • 16. [Results of the use of plasmapheresis in the treatment of Rh incompatibility].
    Czeszyńska M; Cretti A; Rzechuła H; Malinowska-Szutowicz Z
    Acta Haematol Pol; 1988; 19(1-2):47-55. PubMed ID: 3149110
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of the fetus with Rh incompatibility by the combined methods of plasmapheresis and intrauterine blood transfusion].
    Lozińska D; Radomska I; Samborska K; Dmoch E; Garwoliński J; Lenkiewicz B; Góralski T
    Pol Tyg Lek; 1988 Nov; 43(45):1449-51. PubMed ID: 3151013
    [No Abstract]   [Full Text] [Related]  

  • 18. Dwindling supplies of anti-D.
    Beveridge HE
    Med J Aust; 1997 Nov; 167(9):509-10. PubMed ID: 9397073
    [No Abstract]   [Full Text] [Related]  

  • 19. The continuing struggle to eliminate hemolytic disease of the newborn from RH (D).
    Barlow JF
    S D J Med; 1999 Jan; 52(1):7-8. PubMed ID: 9926725
    [No Abstract]   [Full Text] [Related]  

  • 20. The global burden of Rh disease.
    Zipursky A; Paul VK
    Arch Dis Child Fetal Neonatal Ed; 2011 Mar; 96(2):F84-5. PubMed ID: 21037283
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.